Biocompatibility issues in hemodialysis.
Hemodialysis, as a life-saving treatment modality for uremic patients, implies a repeated and compulsory contact of blood with foreign materials.  As a consequence, biocompatibility problems are unavoidable. The same applies for the material used for the creation of vascular access, and for the alternative dialysis method, CAPD (continuous ambulatory peritoneal dialysis), although each system might cause its own and specific problems.  Although in early dialysis the focus has been on maintenance of life and elimination of toxins, later on the important morbid implications of this lack of biocompatibility have been recognized. Eight major problems will be discussed, especially in the perspective of recent new findings in this field:  (1) coagulation and clotting; (2) complement and leukocyte activation; (3) susceptibility to infection; (4) leaching or spallation; (5) surface alterations of solid materials; (6) allergic reactions; (7) shear; (8) transfer of compounds from contaminated dialysate. After description of the major biochemical and clinical implications of these problems, ways to prevent morbid events and future perspectives will be described.
Nephrology Department, University Hospital, Ghent, Belgium.
R
R
Vanholder
D001672:Biocompatible Materials / Q000009:adverse effects*; D001777:Blood Coagulation; D003167:Complement Activation; D004867:Equipment Design; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000517:prevention & control; D017053:Infection Control; D007239:Infections / Q000209:etiology; D007962:Leukocytes; D006435:Renal Dialysis / Q000009:adverse effects*; D013314:Stress, Mechanical; D013499:Surface Properties; D014511:Uremia / Q000150:complications / Q000276:immunology / Q000628:therapy*